| 1 |
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Roy A. Black, Charles T. Rauch, Carl J. Kozlosky et al. · Nature
|
Feb 1997 |
3,168 |
| 2 |
RANK is essential for osteoclast and lymph node development
William C. Dougall, Moira B. Glaccum, K Charrier et al. · Genes & Development
Open access |
15 Sep 1999 |
1,506 |
| 3 |
Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
Kenneth H. Grabstein, June Eisenman, Kurt D. Shanebeck et al. · Science
|
13 May 1994 |
1,432 |
| 4 |
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
Thomas B. Brunner, Rona J. Mogil, Drake LaFace et al. · Nature
Open access |
Feb 1995 |
1,342 |
| 5 |
ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor
David J. Cosman, Jürgen Müllberg, Claire L. Sutherland et al. · Immunity
Open access |
Feb 2001 |
1,218 |
| 6 |
Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.
Eugene Maraskovsky, Kenneth Brasel, Mark Teepe et al. · The Journal of Experimental Medicine
Open access |
Nov 1996 |
1,134 |
| 7 |
Human IL-17: a novel cytokine derived from T cells
Zemin Yao, Sally L. Painter, William C. Fanslow et al. · The Journal of Immunology
|
Dec 1995 |
1,033 |
| 8 |
Molecular and biological characterization of a murine ligand for CD40
Richard J. Armitage, William C. Fanslow, Laura D. Strockbine et al. · Nature
|
May 1992 |
1,031 |
| 9 |
Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15.
Judith G. Giri, Minoo Ahdieh, June Eisenman et al. · The EMBO Journal
Open access |
Jun 1994 |
998 |
| 10 |
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Francesco Colotta, Fabio Re, Marta Muzio et al. · Science
|
23 Jul 1993 |
988 |
| 11 |
Identification of a ligand for the c-kit proto-oncogene
Douglas E. Williams, June Eisenman, Allison M. Baird et al. · Cell
|
Oct 1990 |
957 |
| 12 |
Fas ligand mediates activation-induced cell death in human T lymphocytes.
Mark R. Alderson, Teresa W. Tough, Terri Davis‐Smith et al. · The Journal of Experimental Medicine
Open access |
1995 |
957 |
| 13 |
The IL-6 Signal Transducer, gp130: an Pncostatin M Receptor and Affinity Converter for the LIF Receptor
David P. Gearing, Michael R. Comeau, Della J. Friend et al. · Science
|
13 Mar 1992 |
900 |
| 14 |
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
Hilary J. McKenna, Kim L. Stocking, Robert E. Miller et al. · Blood
|
Jun 2000 |
895 |
| 15 |
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
K M Mohler, Dauphine Torrance, Carole Smith et al. · The Journal of Immunology
|
Aug 1993 |
838 |
| 16 |
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
R.Cutler Allen, Richard J. Armitage, Mary Ellen Conley et al. · Science
|
12 Feb 1993 |
836 |
| 17 |
TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation
Jacques J. Peschon, Dauphine Torrance, Kim L. Stocking et al. · The Journal of Immunology
Open access |
1998 |
715 |
| 18 |
A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules
David J. Cosman, Neil A. Fanger, Luís Borges et al. · Immunity
Open access |
Aug 1997 |
694 |
| 19 |
A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.
Catherine J. McMahan, Jennifer L. Slack, Bruce Mosley et al. · The EMBO Journal
Open access |
Oct 1991 |
684 |
| 20 |
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
Thomas S. Griffith, Wilson Chin, Glenn C. Jackson et al. · The Journal of Immunology
Open access |
Sep 1998 |
671 |
| 21 |
Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Elaine W. Raines, Steven Dower, Russell Ross · Science
|
20 Jan 1989 |
648 |
| 22 |
Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor.
Judith G. Giri, Satoru Kumaki, Minoo Ahdieh et al. · The EMBO Journal
Open access |
Aug 1995 |
647 |
| 23 |
Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
Mark Kennedy, Dauphine Torrance, Kathleen S. Picha et al. · The Journal of Immunology
|
Oct 1992 |
622 |
| 24 |
Interleukin 1 signaling occurs exclusively via the type I receptor.
John E. Sims, Margit A. Gayle, Jennifer L. Slack et al. · Proceedings of the National Academy of Sciences
Open access |
Jul 1993 |
611 |
| 25 |
CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.
Mark R. Alderson, Richard J. Armitage, Teresa W. Tough et al. · The Journal of Experimental Medicine
Open access |
Aug 1993 |
587 |
| 26 |
A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene, mdr1a, Spontaneously Develop Colitis
Chetan M Panwala, Jon C. Jones, Joanne L. Viney · The Journal of Immunology
Open access |
Nov 1998 |
571 |
| 27 |
Humoral immune responses in CD40 ligand-deficient mice.
Blair R. Renshaw, William C. Fanslow, Richard J. Armitage et al. · The Journal of Experimental Medicine
Open access |
Nov 1994 |
540 |
| 28 |
Fas transduces activation signals in normal human T lymphocytes.
Mark R. Alderson, Richard J. Armitage, Eugene Maraskovsky et al. · The Journal of Experimental Medicine
Open access |
Dec 1993 |
524 |
| 29 |
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.
Jonathan Kaye, Steven A. Gillis, S B Mizel et al. · The Journal of Immunology
|
Sep 1984 |
524 |
| 30 |
An early India-Asia contact: Paleomagnetic constraints from Ninetyeast Ridge, ODP Leg 121
Chris T. Klootwijk, J. S. Gee, John W. Peirce et al. · Geology
|
1992 |
512 |
| 31 |
Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting Enzyme
Pranhitha Reddy, Jennifer L. Slack, Raymond Davis et al. · Journal of Biological Chemistry
Open access |
May 2000 |
503 |
| 32 |
CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells.
Philip Morrissey, K Charrier, Steve Braddy et al. · The Journal of Experimental Medicine
Open access |
Jul 1993 |
476 |
| 33 |
Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas
HJ Gruss, Steven Dower · Blood
|
15 Jun 1995 |
458 |
| 34 |
TRAIL: a molecule with multiple receptors and control mechanisms
Thomas S. Griffith, David H. Lynch · Current Opinion in Immunology
Review |
Oct 1998 |
455 |
| 35 |
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice
Bali Pulendran, Jai Lingappa, Mark Kennedy et al. · The Journal of Immunology
|
Sep 1997 |
446 |
| 36 |
IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation.
R J Armitage, Brian M. Macduff, June Eisenman et al. · The Journal of Immunology
|
1995 |
443 |
| 37 |
Use of defined TLR ligands as adjuvants within human vaccines
Malcolm S. Duthie, Hillarie Plessner Windish, Christopher B. Fox et al. · Immunological Reviews
ReviewOpen access |
28 Dec 2010 |
442 |
| 38 |
Generation of murine dendritic cells from flt3-ligand–supplemented bone marrow cultures
Kenneth Brasel, Thibaut De Smedt, Jeffery L. Smith et al. · Blood
|
Nov 2000 |
439 |
| 39 |
Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction
Uno Shu, Mamoru Kiniwa, Chang You Wu et al. · European Journal of Immunology
|
Apr 1995 |
419 |
| 40 |
Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail)
Neil A. Fanger, Charles R. Maliszewski, Ken Schooley et al. · The Journal of Experimental Medicine
Open access |
18 Oct 1999 |
413 |
| 41 |
Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo
Bali Pulendran, Jacques Banchereau, Susan B. Burkeholder et al. · The Journal of Immunology
|
Jul 2000 |
411 |
| 42 |
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma
Larry Borish, Harold S. Nelson, Jonathan Corren et al. · Journal of Allergy and Clinical Immunology
Open access |
Jun 2001 |
411 |
| 43 |
Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.
Melanie K. Spriggs, Richard J. Armitage, Laura D. Strockbine et al. · The Journal of Experimental Medicine
Open access |
Dec 1992 |
403 |
| 44 |
A Lymphotoxin-β-Specific Receptor
Paul D. Crowe, Todd L. VanArsdale, Barbara N. Walter et al. · Science
|
29 Apr 1994 |
401 |
| 45 |
In vivo generation of human dendritic cell subsets by Flt3 ligand
Eugene Maraskovsky, Elizabeth Daro, Eileen R. Roux et al. · Blood
|
Aug 2000 |
399 |
| 46 |
Safety and Efficacy of a Soluble P75 Tumor Necrosis Factor Receptor (Enbrel, Etanercept) in Patients With Advanced Heart Failure
Anita Deswal, Biykem Bozkurt, Yukihiro Seta et al. · Circulation
|
29 Jun 1999 |
396 |
| 47 |
Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure
Biykem Bozkurt, Guillermo Torre‐Amione, Marshelle Smith Warren et al. · Circulation
|
27 Feb 2001 |
389 |
| 48 |
Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
Moira B. Glaccum, Kim L. Stocking, K Charrier et al. · The Journal of Immunology
|
Oct 1997 |
387 |
| 49 |
Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers
Mitsuru Matsumoto, Sanjeev Mariathasan, Moon H. Nahm et al. · Science
|
Mar 1996 |
382 |
| 50 |
Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes.
Fred D. Finkelman, Kathleen B. Madden, Suzanne C. Morris et al. · The Journal of Immunology
|
Aug 1993 |
368 |